ARIA-EAACI statement on Asthma and COVID-19
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F21%3A73601147" target="_blank" >RIV/61989592:15110/21:73601147 - isvavai.cz</a>
Result on the web
<a href="https://pubmed.ncbi.nlm.nih.gov/32588922/" target="_blank" >https://pubmed.ncbi.nlm.nih.gov/32588922/</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/all.14471" target="_blank" >10.1111/all.14471</a>
Alternative languages
Result language
angličtina
Original language name
ARIA-EAACI statement on Asthma and COVID-19
Original language description
A novel strain of human coronaviruses, the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), named by the International Committee on Taxonomy of Viruses (ICTV),1 has recently emerged and caused an infectious disease. This disease is referred to as the “coronavirus disease 2019” (COVID‐19) by the World Health Organization (WHO).2 The US Centers for Disease Control and Prevention (CDC) have proposed that “People with moderate to severe asthma may be at higher risk of getting very sick from COVID‐19. COVID‐19 can affect your respiratory tract (nose, throat, lungs), cause an asthma attack and possibly lead to pneumonia and acute respiratory disease.” (May 24, 2020). (https://www.cdc.gov/coronavirus/2019‐ncov/need‐extra‐precautions/asthma.html) On the other hand, in the UK, NICE proposes rapid guidelines for severe asthma (https://www.guidelines.co.uk/covid‐19‐rapid‐guideline‐severe‐asthma/455275.article). An ARIA‐EAACI statement has been devised to make recommendations on asthma, and not necessarily on severe asthma, based on a consensus from its members. It is difficult in many studies to clearly assess the prevalence of asthma on COVID‐19 since most patients are older adults and probably have multimorbidities. Most studies do not clarify whether asthmatic patients with COVID‐19 have isolated asthma or asthma as a multimorbidity, particularly in the context of hypertension, obesity and diabetes. In particular, obesity is a significant risk factor for COVID‐19 and its severity,3 and may be intertwined with asthma.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30203 - Respiratory systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
ALLERGY
ISSN
0105-4538
e-ISSN
—
Volume of the periodical
76
Issue of the periodical within the volume
3
Country of publishing house
GB - UNITED KINGDOM
Number of pages
9
Pages from-to
689-697
UT code for WoS article
000571269800001
EID of the result in the Scopus database
2-s2.0-85091138547